journal article Jun 08, 2023

Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model

Cancer Biomarkers Vol. 37 No. 2 pp. 95-107 · SAGE Publications
View at Publisher Save 10.3233/cbm-210445
Abstract
INTRODUCTION: Ferroptosis is a recently discovered type of programmed cell death that plays a crucial role in tumor occurrence and progression. However, no prognostic model has been established yet for clear cell renal cell carcinoma (ccRCC) using ferroptosis-related long non-coding RNAs (lncRNAs). METHODS: In the present study, lncRNA expression profiles, sex, age, TMN stage, and other clinical data of ccRCC samples were extracted from The Cancer Genome Atlas database. In addition, ferroptosis-related lncRNAs were identified using co-expression analysis, and the risk model was established using Cox regression and least absolute shrinkage and selection operator regression analyses. Log-rank test and Kaplan-Meier analysis were performed to evaluate the predictive accuracy of the risk model for the overall survival (OS) of patients with ccRCC. Moreover, the functional enrichment of ferroptosis-related lncRNAs was performed and visualized using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes. RESULTS: Eight prognostic ferroptosis-related lncRNAs were identified, such as LINC01615, AC026401.3, LINC00944, AL590094.1, DLGAP1-AS2, AC016773.1, AC147651.1, and AP000439.2, making up the ferroptosis-related lncRNA risk model. The risk model effectively divided patients with ccRCC into high- and low-risk groups, and their survival time was calculated. The high-risk group showed significantly shorter OS compared to the low-risk group. The nomogram to predict the survival rate of the patients revealed that the risk score was the most critical factor affecting OS in patients with ccRCC. The ferroptosis-related lncRNA risk model was an independent predictor of prognostic risk assessment in patients with ccRCC. CONCLUSION: The ferroptosis-related lncRNAs risk model and genomic clinicopathological nomogram have the potential to accurately predict the prognosis of patients with ccRCC and could serve as potential therapeutic targets in the future.
Topics

No keywords indexed for this article. Browse by subject →

References
34
[1]
Nabi "Renal cell carcinoma: A review of biology and pathophysiology" F1000Res (2018) 10.12688/f1000research.13179.1
[2]
Zhao "Dynamic prognostic model for kidney renal clear cell carcinoma (KIRC) patients by combining clinical and genetic information" Sci Rep (2018) 10.1038/s41598-018-35981-5
[3]
Chang "Ferroptosis-related gene signature accurately predicts survival outcomes in patients with clear-cell renal cell carcinoma" Front Oncol (2021) 10.3389/fonc.2021.649347
[4]
Renal cancer

Umberto Capitanio, Francesco Montorsi

The Lancet 2016 10.1016/s0140-6736(15)00046-x
[5]
Weiss "Metabolomics and metabolic reprogramming in kidney cancer" Semin Nephrol (2018) 10.1016/j.semnephrol.2018.01.006
[6]
Ferroptosis: machinery and regulation

Xin Chen, Jingbo Li, Rui Kang et al.

Autophagy 2021 10.1080/15548627.2020.1810918
[7]
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al.

Cell 2012 10.1016/j.cell.2012.03.042
[8]
Zhang "BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression" Mol Cell Oncol (2019) 10.1080/23723556.2018.1536845
[9]
Hassannia "Targeting ferroptosis to iron out cancer" Cancer Cell (2019) 10.1016/j.ccell.2019.04.002
[10]
Du "Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells" Phytomedicine (2021) 10.1016/j.phymed.2021.153551
[11]
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

Brent R. Stockwell, José Pedro Friedmann Angeli, Hulya Bayir et al.

Cell 2017 10.1016/j.cell.2017.09.021
[12]
Wang "Molecular mechanisms of long noncoding RNAs" Mol Cell (2011) 10.1016/j.molcel.2011.08.018
[13]
Fedorko "Long non-coding RNAs and renal cell carcinoma" Klin Onkol (2020)
[14]
Jin "The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer" RNA Biol (2020) 10.1080/15476286.2020.1737787
[15]
Zhang "Long noncoding RNA: A crosslink in biological regulatory network" Brief Bioinform (2018) 10.1093/bib/bbx042
[16]
Wang "LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer" Mol Cancer (2019) 10.1186/s12943-019-1105-0
[17]
Su "Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers" Front Oncol (2021) 10.3389/fonc.2021.719564
[18]
Chowdhury "Variable selection strategies and its importance in clinical prediction modelling" Fam Med Community Health (2020) 10.1136/fmch-2019-000262
[19]
Rades "An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer" Transl Lung Cancer Res (2020) 10.21037/tlcr-19-642
[20]
Yang "Surgical treatment outcomes of spinal metastases of nasopharyngeal carcinoma: The first report of 30 patients from a single center" Cancer Manag Res (2020) 10.2147/cmar.s257685
[21]
V. Patel, R. Elias, J. Formella, W. Schwartzman, A. Christie, Q. Cai, V. Malladi, P. Kapur, M. Vazquez, R. McKay, I. Pedrosa, R. Hannan, H. Hammers and J. Brugarolas, Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma, J Immunother Cancer 8 (2020). 10.1136/jitc-2020-001198
[22]
Zabell "Predictors of long-term survival after renal cancer surgery" J Urol (2018) 10.1016/j.juro.2017.08.096
[23]
Miao "LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression" J Biochem (2020) 10.1093/jb/mvz108
[24]
Chen "lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation" Biomed Res Int (2020)
[25]
Ren "A three long non-coding RNA signature to improve survival prediction in patients with Wilms’ tumor" Oncol Lett (2019)
[26]
Liu "The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10" FEBS Open Bio (2021) 10.1002/2211-5463.13061
[27]
Sabbir Ahmed "Integrative Analysis of lncRNA-mRNA Coexpression in Human Lung Epithelial Cells Exposed to Dimethyl Selenide-Derived Secondary Organic Aerosols" Chem Res Toxicol (2021) 10.1021/acs.chemrestox.0c00516
[28]
de Santiago "Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis" Life Sci (2021) 10.1016/j.lfs.2020.118956
[29]
Kong "Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers" J Cell Biochem (2019) 10.1002/jcb.29063
[30]
J. Wang, C. Zhang, W. He and X. Gou, Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma, J Cell Biochem (2018). 10.1002/jcb.27557
[31]
Hu "Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis" Cancer Biomark (2020) 10.3233/cbm-190694
[32]
Ji "Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma" J Cell Physiol (2019) 10.1002/jcp.27963
[33]
Qi "A new method for excavating feature lncRNA in lung adenocarcinoma based on pathway crosstalk analysis" J Cell Biochem (2019) 10.1002/jcb.28177
[34]
Xiang "Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy" Bioengineered (2021) 10.1080/21655979.2021.1924546